A nasal COVID-19 vaccine formulation is one of several new technologies under consideration, Acting FDA Commissioner Janet Woodcock said. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
